一、产品概述
ENMD-2076 是来自Absin品牌的高品质产品,适用于科研实验领域。
更多产品描述请查看优宁维旗下爱必信官网(https://www.absin.cn/enmd-2076-tartaric-acid/abs817731.html?mk_channel=chemicalbook)
二、产品信息
| 货号 | abs817731 |
| SKU货号 | abs817731-2mg |
| 品牌 | Absin |
| 中文名称 | ENMD-2076 |
| 英文名称 | ENMD-2076 L-(+)-Tartaric acid |
| CAS号 | 1291074-87-7 |
| 纯度 | 98% |
| 分子量 | 525.56 |
| 可溶性 | DMSO:100 mg/mL warmed (190.27 mM) |
| 抗原名称 | FLT3,RET,Aurora A,VEGFR3/FLT4,Src,, |
商品描述
ENMD-2076 L-(+)-Tartaric acid is the tartaric acid of ENMD-2076, selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold more selective for Aurora A than Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 and PDGFRα. Phase 2.
In vitro(体外研究)
ENMD-2076 indicates activity against multiple kinases involved in angiogenesis, including FLT3, RET, FLT4/VEGFR3, SRC, NTRK1, CSF1R/FMS, LCK, VEGFR2/KDR, FGFR1/2, and PDGFRα with IC50 from 1.86-120 nM. ENMD-2076 inhibits the growth of a wide range of human solid tumor and hematopoietic cancer cell lines with IC50 from 0.025-0.7 μM, which induces apoptosis and G2/M phase arrest. ENMD-2076 induces regression or complete inhibition of tumor growth in tumor xenograft models derived from breast, colon, melanoma, leukemia, and multiple myeloma cell lines. ENMD-2076 is the L (+) tartrate salt of ENMD-981693. ENMD-2076 shows significant cytotoxicity against myeloma cell lines (IM9, ARH-77, U266, RPMI 8226, MM.1S, MM.1R, NCI-H929) and primary cells with IC50 from 2.99 to 7.06 μM, which induces apoptosis. ENMD-2076 indicates low cytotoxicity to haematopoietic progenitors. ENMD-2076 inhibits the phosphoinositide 3-kinase/Akt pathway and downregulates survivin and X-linked inhibitor of apoptosis. ENMD-2076 also inhibits aurora A and B kinases, and induces G2/M cell cycle arrest.
In vivo(体内研究)
ENMD-2076 has sustained inhibitory effects on the activation of Flt3 as well as VEGFR2/KDR and FGFR1/2 in HT29 xenograft model. ENMD-2076 could prevent the formation of new blood vessels and regress formed vessels in MDA-MB-231 xenograft model. Oral treatment with ENMD-2076 (50, 100, 200 mg/kg per day) inhibits the tumour growth in H929 human plasmacytoma xenografts, with significant reduction in phospho-Histone 3 (pH3), Ki-67, and angiogenesis, and also a significant increase in cleaved caspase-3.
三、背景
四、制备和贮存
| 保存方式 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
五、产品特点
- 品质保证:经过严格的质量控制,确保产品的高品质和稳定性。
- 高纯度:纯度达到<p>98%</p>。
六、注意事项
- 本产品仅供科学研究使用,不可用于临床诊断或治疗。
- 请在通风良好的环境下操作,佩戴适当的个人防护装备。
- 如不慎接触皮肤或眼睛,请立即用大量清水冲洗并就医。